BFA
SRPT icon

BlackRock Fund Advisors’s Sarepta Therapeutics SRPT Stock Holding History

BlackRock Fund Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$62M Buy
2,258,531
+536,583
+31% +$21.6M 0.01% 1543
2016
Q3 		$106M Buy
1,721,948
+116,101
+7% +$3.51M 0.02% 1013
2016
Q2 		$30.6M Sell
1,605,847
-55,971
-3% -$1.04M 0.01% 1792
2016
Q1 		$32.4M Buy
1,661,818
+36,371
+2% +$635K 0.01% 1713
2015
Q4 		$62.7M Buy
1,625,447
+55,431
+4% +$1.8M 0.01% 1317
2015
Q3 		$50.4M Buy
1,570,016
+41,183
+3% +$1.4M 0.01% 1417
2015
Q2 		$46.5M Sell
1,528,833
-32,159
-2% -$658K 0.01% 1574
2015
Q1 		$20.7M Buy
1,560,992
+45,301
+3% +$604K 0.01% 2049
2014
Q4 		$21.9M Buy
1,515,691
+134,357
+10% +$2.28M 0.01% 2019
2014
Q3 		$29.1M Sell
1,381,334
-9,310
-0.7% -$210K 0.01% 1721
2014
Q2 		$41.4M Sell
1,390,644
-18,970
-1% -$600K 0.01% 1524
2014
Q1 		$33.9M Buy
1,409,614
+46,461
+3% +$1.18M 0.01% 1683
2013
Q4 		$27.8M Buy
1,363,153
+136,242
+11% +$4.05M 0.01% 1790
2013
Q3 		$57.9M Buy
1,226,911
+209,318
+21% +$8.06M 0.02% 1210
2013
Q2 		$38.7M Buy
+1,017,593
New +$36.4M 0.01% 1416

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock Fund Advisors's SRPT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Sarepta Therapeutics (SRPT) stake by 31% in Q4 2016, buying an estimated $21.6M and bringing the position to 2,258,531 shares worth $62M. The position accounts for 0.01% of the portfolio, ranked #1543.

BlackRock Fund Advisors first reported a position in SRPT in Q2 2013 and has held it in 15 quarters since. The position peaked at $106M in Q3 2016. 178 funds tracked by Wall St. Rank hold SRPT as of Q4 2016.

  • BlackRock Fund Advisors held 2,258,531 shares of Sarepta Therapeutics worth $62M as of Q4 2016.
  • BlackRock Fund Advisors bought 536,583 Sarepta Therapeutics shares in Q4 2016, an estimated $21.6M.
  • Sarepta Therapeutics made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1543 holding.
  • BlackRock Fund Advisors first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Sarepta Therapeutics position peaked at $106M in Q3 2016.
  • 178 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.